Article Text
Abstract
Lyme disease (borreliosis) is a tick-borne bacterial infection caused by the spirochaete Borrelia burgdoferi, transmitted by hard-backed Ixodes ticks. Actual numbers of cases are increasing and it appears that the distribution across the UK is widening; however, it occurs most frequently in area of woodland, with temperate climate. It typically presents in mid to late summer. Lyme disease is a multisystem disease. The nervous system is the second most commonly affected system after the skin. Other systemic manifestations, such as carditis, keratitis, uveitis and inflammatory arthritis, rarely occur in European Lyme disease. In 2018, the National Institute for Health and Care Excellence has updated its guidelines on the diagnosis and management of Lyme disease. Here, we highlight important aspects of this guidance and provide a more detailed review of the clinical spectrum of neuroborreliosis, illustrated by cases we have seen.
- lyme disease
- neuroborreliosis
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Lyme borreliosis: diagnosis and management
- Lyme disease in the United Kingdom
- Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable
- Diagnosis and treatment of Lyme disease in children
- Seronegative lyme neuroborreliosis in a patient using rituximab
- Woman with lower back pain, SIADH and a twist of Lyme
- Cranial neuropathy and severe pain due to early disseminated Borrelia burgdorferi infection
- Protracted neuroborreliosis – an unusual cause of encephalomyelitis
- Clinical features of double infection with tick-borne encephalitis and Lyme borreliosis transmitted by tick bite
- Lyme radiculopathy in a septuagenarian